Bradley Leshnower is a Cardiology physician affiliated with Emory Healthcare. OpenAlex indexes 307 publications with 6,898 citations (h-index 46); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingClinical trials
- Neurologic Injury Following Aortic Arch Replacement
Sponsor: Emory University
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
6 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
6 companies with payments on record in CMS Open Payments (2021 onward), matched to this physician's NPI. The itemized breakdown by company, amount and year is part of the full profile. Why? →
NIH funding
1 NIH research award on record, funded 2021–2024 per NIH RePORTER. The latest:
- Risk stratification of uncomplicated type B aortic dissection using clinical and engineering analysis
Emory University
FY2024$534,965R01HL155537 - Risk stratification of uncomplicated type B aortic dissection using clinical and engineering analysis
Emory University
FY2023$548,005R01HL155537 - Risk stratification of uncomplicated type B aortic dissection using clinical and engineering analysis
Emory University
FY2022$552,082R01HL155537
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Tixagevimab–cilgavimab for treatment of patients hospitalised with COVID-19: a randomised, double-blind, phase 3 trial
The Lancet Respiratory Medicine
2022 - A Randomized Trial of Mesenchymal Stromal Cells for Moderate to Severe Acute Respiratory Distress Syndrome from COVID-19
American Journal of Respiratory and Critical Care Medicine
2022 - Survival after operative repair of acute type A aortic dissection varies according to the presence and type of preoperative malperfusion
Journal of Thoracic and Cardiovascular Surgery
2022 - Sex-Based Aortic Dissection Outcomes From the International Registry of Acute Aortic Dissection
The Annals of Thoracic Surgery
2021
Similar KOLs
Other experts from the same institution or the same specialty.
Allan Levey, MD, PhD
Emory Healthcare
William Blum, MD
Emory Healthcare
Mehmet Bilen, MD
Emory Healthcare
Ram Subramanian, MD
Emory Healthcare
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Harlan Krumholz, MD
Yale School of Medicine
Scott Solomon, MD
Brigham and Women's Hospital
Eric Topol, MD
Scripps Research Institute (Scripps Research)
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”